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ABSTRACT
Enterococcus faecium is an emerging nosocomial pathogen associated with 
antibiotic therapy in the hospital environment. Whole-genome sequences were 
determined for three pairs of related, consecutively collected E. faecium clinical 
isolates to determine putative mechanisms of resistance to tigecycline. The first 
isolates (1S, 2S and 3S) in each of the three pairs were sensitive to tigecycline
[minimum inhibitory concentration (MIC) of 0.125 mg/L]. Following tigecycline 
therapy, the second isolate in each pair demonstrated increased resistance to 
tigecycline. Two isolates (1R and 2R) were resistant (MIC of 8 mg/L) and one isolate
(3I) demonstrated reduced susceptibility (MIC of 0.5 mg/L). Mutations distinguishing 
each pair of sensitive and resistant isolates were determined through alignment to a 
reference genome and variant detection. In addition, a de novo assembly of each 
isolate genome was constructed to confirm mutations. A total of 16 mutations in 
eleven coding sequences were determined. Mutations in the rpsJ gene, which 
encodes a structural protein forming part of the 30S ribosomal subunit, were 
detected in each of the pairs. Mutations were in regions proximal to the predicted 
tigecycline-binding site. Predicted amino acid substitutions were detected in 1R and 
3I. The resistant strains were additionally associated with deletions of 15 nucleotides 
(2R) and 3 nucleotides (1R). This study confirms that amino acid substitutions in rpsJ
contribute towards reduced susceptibility to tigecycline and suggests that deletions 
may be required for tigecycline resistance in E. faecium.
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1. Introduction
Enterococcus faecium is a nosocomial pathogen associated with antibiotic therapy in 
the hospital environment that is increasing in prevalence [1,2]. Compared with
Enterococcus faecalis, which remains the most common Enterococcus species in 
clinical infections, E. faecium is intrinsically resistant to a greater number of
antibiotics and can efficiently acquire additional antibiotic resistance mechanisms
necessitating the use of alternative antibiotics for therapy. Vancomycin resistance is 
a common and pressing clinical problem in Enterococcus. This results from 
transposon-mediated insertion of genes coding for vancomycin-inactivating 
enzymes. Tigecycline, a derivative of minocycline, has bacteriostatic activity through 
binding to the 30S subunit of the bacterial ribosome and inhibiting protein synthesis
[2,3]. It provides broad-spectrum activity against multiresistant pathogens such as
meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant 
enterococci (VRE), and Enterobacteriaceae with extended-spectrum -lactamases
(ESBLs) or carbapenemases. Tigecycline resistance has been reported [3], mainly in
Gram-negative pathogens, e.g. Acinetobacter baumannii and Klebsiella pneumoniae
[4,5], although rarely also in Gram-positive pathogens such as E. faecalis and MRSA
[6,7]. Tigecycline resistance is most commonly associated with overexpression of 
efflux pumps, e.g. MarA-mediated overexpression of AcrAB in Escherichia coli [3,8].
Whole-genome sequencing (WGS) is a powerful technique that can be used to 
pinpoint mutations that arise in clinical isolates which have been exposed to 
antibiotics during treatment. This technique has allowed detailed analysis of pairs of 
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consecutively isolated tigecycline-susceptible and -resistant isolates of Gram-
negative pathogens to be undertaken [5,9]. In this study, WGS was used to
investigate the nature of potential mechanism(s) associated with tigecycline 
resistance and reduced susceptibility in three VRE clinical isolates.
2. Materials and methods
2.1. Bacterial isolates
Two pairs of isolates (1S and 1R, and 3S and 3I) were obtained from patients in a 
hospital in the West Midlands, UK. Both patients were previous liver transplant 
recipients and had been diagnosed with hepatic artery thrombosis and intrahepatic 
collections. A tigecycline-resistant VRE (1R) was isolated from the first patient 
following a total of 38 days of treatment with tigecycline. The VRE isolate with 
reduced susceptibility to tigecycline (3I) was isolated following two courses of 
tigecycline, totalling 43 days of treatment. A third pair consisted of two isolates (2S 
and 2R), which despite originating from different patients belonged to a persistent 
endemic clone [determined by pulsed-field gel electrophoresis (PFGE)], isolated in a 
hospital in Scotland. Isolate 2S was cultured from urine from a renal patient, whereas 
isolate 2R was grown from a rectal VRE screening sample in a patient with complex 
intra-abdominal infection who had received tigecycline for only 3 days.
2.2. Antimicrobial susceptibility testing
Minimum inhibitory concentrations (MICs) were determined by agar dilution or Etest 
(AB bioMérieux, Solna, Sweden) on Iso-Sensitest agar (Oxoid Ltd., Basingstoke, 
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UK) and were interpreted according to British Society for Antimicrobial 
Chemotherapy (BSAC) guidelines [10].
2.3. Whole-genome sequencing
DNA was extracted using an Ultraclean® Microbial DNA Kit (Cambio Ltd., 
Cambridge, UK) for 1S, 1R, 3S and 3I according to the manufacturer’s instructions 
and was quantified using the dsDNA HS Assay on a Qubit® fluorometer (Thermo 
Fisher Scientific, Renfrew, UK). Using 1 ng of input DNA, sequencing libraries were
then generated using a Nextera XT Sample Preparation Kit (Illumina, Great 
Chesterford, UK) according to the manufacturer’s recommendations. Sequencing 
was performed on a MiSeqTM Sequencing System (Illumina) using v2 reagents and 
generated 300 base (forward) and 200 base (reverse) paired-end reads. For isolates 
2S and 2R, DNA was extracted using a Wizard Genomic DNA Purification Kit
(Promega, Madison, WI) and was sequenced on a HiSeqTM 2000 instrument 
(Illumina) using 90 base paired-end reads at the Beijing Genomics Institute 
(Shenzhen, China).
2.4. Genome analysis
Raw reads were adapter and quality trimmed using Trimmomatic
(http://www.usadellab.org/cms/?page=trimmomatic). Reads were aligned against the 
E. faecium DO reference genome (accession no. NC_017960.1) using BWA-MEM
(https://github.com/lh3/bwa), variants were called using VarScan2 with an allele 
frequency threshold of 80%, and the effect on coding sequences was predicted 
using SnpEff (http://snpeff.sourceforge.net). In addition, to confirm that complex 
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mutations in rpsJ did not result from mapping artefacts, a de novo assembly was
performed on each sample using SPAdes 2.5.0 (http://bioinf.spbau.ru/spades) with 
default parameters. The location of the rpsJ sequence in each draft assembly was 
determined by BLASTX, and matching sequences were aligned using ClustalW2
(http://www.ebi.ac.uk/Tools/msa/clustalw2). To look for changes in gene content 
between pairs of isolates, the draft genome assemblies for each isolate were 
compared using the LS-BSR pipeline (https://github.com/jasonsahl/LS-BSR). The 
python script compare_BSR.py from the same package was used to compare the 
resistant or intermediate isolate against the sensitive isolate for each pair. Multilocus 
sequence typing (MLST) sequence types were determined in silico from the de novo 
assemblies using the python script mlst (https://github.com/Victorian-Bioinformatics-
Consortium/mlst). The nucleotide sequences of the E. faecium isolates described in 
this work have been deposited at the European Nucleotide Archive under the study 
accession no. PRJEB7380 (http://www.ebi.ac.uk/ena/data/view/PRJEB7380).
3. Results and discussion
The antibiotic susceptibility profiles revealed increased resistance to tigecycline in 
each of the three post-therapy isolates (Table 1). Each of the pairs showed different 
mutations in rpsJ, which encodes the S10 structural protein in the small 30S 
ribosomal subunit.
Comparison of genomes for pair 1 showed a codon deletion (ATC) and a non-
synonymous transition (T>C) mutation. Pair 2 had a deletion of five codons 
(ATCCGTGCGACTCAT). Pair 3 had two non-synonymous transversion (C>A and 
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A>G) mutations (Fig. 1). All detected mutations were found in close proximity, 
corresponding to amino acid positions 52–60 in E. coli K-12.
Tigecycline resistance may result from changes to the regulation of efflux pumps,
with other reported mechanisms including enzymatic degradation [3]. In the current 
study, we did not find evidence for such mutations (Supplementary Table S1). 
Analysis of gene content demonstrated that neither isolates 1R or 2R were found to 
contain any additional coding sequences compared with their respective sensitive 
counterparts. Isolate 3I, however, was found to contain an additional 73 coding 
sequences, the majority of which were located within a 48-kb region of the genome 
compared with the reference genome Aus004 (GenBank accession no. CP003351). 
We found no annotation evidence of tetA or tetR sequences or additional efflux 
pump-related sequences in this region. There was no commonality between lost or 
gained sequences between isolate pairs, making it unlikely that changes in gene 
content between isolates accounted for the phenotypic changes observed.
A mutation at codon 57 in rpsJ was previously described in a tigecycline-resistant K. 
pneumoniae [9]. It was hypothesised that this mutation, which is in close proximity to 
the tigecycline-binding site, could disturb the ribosomal structure in turn affecting the 
strong affinity of tigecycline to the ribosome. Our analysis indicates that amino acid 
substitutions and deletions contribute to increased tigecycline MICs in E. faecium. 
Notably, Cattoir et al. also suggested that intermediate resistance (MICs of 0.25–0.5 
mg/L) in E. faecium is associated with a single nucleotide substitution in rpsJ 
resulting in a non-synonymous change in the conserved KYKD (to EYKD or KYKY) 
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motif at positions 57–60 [11]. This is important because the mutations are located in 
the same region of rpsJ as the mutations detected here.
However, the single amino acid substitutions detected in their study and ours do not 
appear sufficient to produce a fully tigecycline-resistant phenotype.
According to an X-ray crystal structure of the Thermus thermophilus ribosome, the 
tigecycline-binding site, which is located in the small ribosomal subunit, is composed 
almost exclusively of ribosomal RNA. All of the mutations that increase resistance to 
tigecycline occur in a relatively poorly conserved loop of S10, which appears to be 
involved in maintaining the structure of the tigecycline-binding site [12]. All of the 
mutations that potentially increase resistance substantially (1R and 2R) result in the 
deletion of one or multiple amino acids from this loop and would likely significantly 
distort the tigecycline-binding site. Isolate 1R contains a missense mutation resulting 
in a tyrosine to histidine substitution at position 58 (Supplementary Fig. S1).
Interestingly, T. thermophilus naturally contains a histidine at this position [12], 
suggesting that the substitution could compensate for a destabilisation caused by the 
deletion of isoleucine-52.
Two isolates (2R and 3I) both had mutations in a coding sequence 
HMPREF0351_12599, annotated as a hypothetical protein. Protein domain searches 
of this product identified a YacP-like NYN (N4BP1, YacP-like nuclease) domain. 
YacP proteins are predicted to interact in a processome complex that catalyses the 
maturation of rRNA and tRNA, suggesting this mutation may affect the structure of 
the small subunit of the ribosome [13].
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This study highlights the importance of screening for short insertions and deletions
(indels) as well as single nucleotide polymorphisms when performing mutant 
analysis. The results demonstrate that full resistance is likely to instead depend on a 
further deletion, with or without additional amino acid substitutions. Indels are often 
not specifically looked for during routine bioinformatics analysis owing to historical 
difficulties in mapping reads containing indels when using Illumina short-read 
sequencing, and high indel rates associated with sequencing platforms such as 454, 
Ion Torrent and Pacific Biosciences [14,15]. These mutations will be important when 
constructing databases to perform in silico antibiotic resistance determination directly 
from whole-genome data.
In conclusion, we have shown that tigecycline resistance in E. faecium can arise 
through several alternative evolutionary paths in rpsJ following tigecycline therapy
and that deletions in the coding sequence may be necessary for full resistance in this 
increasingly important nosocomial pathogen. The detection in this study of three 
distinct rpsJ genotypes, in addition to two additional genotypes found in a separate 
study, adds weight to the prediction that mutations in rpsJ are an important cause of 
tigecycline resistance in E. faecium.
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Fig. 1. Mutations identified in the rpsJ gene potentially implicated in tigecycline 
resistance. The relevant amino acid sequence of the early wild-type (WT) isolates in 
comparison with the mutated isolates identified both in the intermediate (3I) and 
resistant (1R and 2R) strains from the current study and those from Cattoir et al. [11]. 
Sequences from Escherichia coli K-12 and Thermus thermophilus are shown for 
context. Codons are numbered according to annotations in E. coli K-12. The 
polymorphic region is indicated with a dotted box, and mutations are indicated by 
asterisks. MIC, minimum inhibitory concentration (in mg/L).Table 1
Antibiotic susceptibilities of Enterococcus faecium isolates
MIC (mg/L) [interpretation a]Isolate MLST
Ampicillin Vancomycin Teicoplanin Linezolid Daptomycin
b
Tigecycline
1S 280 >8 [R] >32 [R] >32 [R] 2 [S] 2 0.125 [S]
1R 280 >8 [R] >32 [R] >32 [R] >8 [R] 2 8 [R]
2S 203 >8 [R] >32 [R] 16 [R] 2 [S] 4 0.125 [S]
2R 203 >8 [R] >32 [R] 8 [R] 1 [S] 4 8 [R]
3S – >8 [R] >32 [R] >32 [R] 4 [S] 1 0.125 [S]
3I – >8 [R] >32 [R] >32 [R] 2 [S] 2 0.5 [I]
MLST, multilocus sequence typing; MIC, minimum inhibitory concentration; R, 
resistant; S, susceptible.
a According to British Society for Antimicrobial Chemotherapy (BSAC) guidelines
[10].
b No BSAC MIC breakpoint is available for this antibiotic for E. faecium.
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Highlights
 Whole-genome sequencing permits de novo detection of antibiotic resistance 
in Enterococcus faecium.
 Reduced susceptibility to tigecycline is associated with substitutions in rpsJ.
 Resistance to tigecycline is associated with deletions in rpsJ.
 Protein modelling indicates that these deletions distort the tigecycline-binding 
site.
